Cargando…
Farnesol, a Potential Efflux Pump Inhibitor in Mycobacterium smegmatis
The active multidrug efflux pump (EP) has been described as one of the mechanisms involved in the natural drug resistance of bacteria, such as mycobacteria. As a result, the development of efflux pumps inhibitors (EPIs) is an important topic. In this study, a checkerboard synergy assay indicated tha...
Autores principales: | Jin, Jing, Zhang, Ji-Yu, Guo, Na, Sheng, Hui, Li, Lei, Liang, Jun-Chao, Wang, Xue-Lin, Li, Yang, Liu, Ming-Yuan, Wu, Xiu-Ping, Yu, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6259160/ https://www.ncbi.nlm.nih.gov/pubmed/21042264 http://dx.doi.org/10.3390/molecules15117750 |
Ejemplares similares
-
Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux
por: De Siena, Barbara, et al.
Publicado: (2020) -
Efflux Pump Inhibition and Resistance Modulation in Mycobacterium smegmatis by Peucedanum ostruthium and Its Coumarins
por: Šimunović, Katarina, et al.
Publicado: (2021) -
Insight into the on/off switch that regulates expression of the MSMEG-3762/63 efflux pump in Mycobacterium smegmatis
por: Campolattano, Nicoletta, et al.
Publicado: (2023) -
Comparative Antibacterial and Efflux Pump Inhibitory Activity of Isolated Nerolidol, Farnesol, and α-Bisabolol Sesquiterpenes and Their Liposomal Nanoformulations
por: Santana, Jorge Ederson Gonçalves, et al.
Publicado: (2023) -
Repurposing Based Identification of Novel Inhibitors against MmpS5-MmpL5 Efflux Pump of Mycobacterium smegmatis: A Combined In Silico and In Vitro Study
por: Shahbaaz, Mohd, et al.
Publicado: (2022)